These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33573372)

  • 1. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
    Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
    Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
    Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction.
    Rhodes KR; Meyer RA; Wang J; Tzeng SY; Green JJ
    Acta Biomater; 2020 Aug; 112():136-148. PubMed ID: 32522714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma.
    Kosmides AK; Meyer RA; Hickey JW; Aje K; Cheung KN; Green JJ; Schneck JP
    Biomaterials; 2017 Feb; 118():16-26. PubMed ID: 27940380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for Tumor Metastasis by Artificial Antigen-Presenting Cells via Targeted Microenvironment Regulation and T-Cell Activation.
    Lu Y; Li L; Du J; Chen J; Xu X; Yang X; Ding C; Mao C
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55890-55901. PubMed ID: 34787393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Antigen-Presenting Cells for Immunotherapies.
    Siefert AL; Fahmy TM; Kim D
    Methods Mol Biol; 2017; 1530():343-353. PubMed ID: 28150213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
    Rhodes KR; Green JJ
    Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
    Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
    Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
    Hickey JW; Vicente FP; Howard GP; Mao HQ; Schneck JP
    Nano Lett; 2017 Nov; 17(11):7045-7054. PubMed ID: 28994285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
    Sunshine JC; Perica K; Schneck JP; Green JJ
    Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
    Giang S; Horwitz DA; Bickerton S; La Cava A
    Front Immunol; 2021; 12():628059. PubMed ID: 34122401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.
    Zhang L; Wang L; Shahzad KA; Xu T; Wan X; Pei W; Shen C
    Cancer Immunol Immunother; 2017 Sep; 66(9):1229-1241. PubMed ID: 28501941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Artificial Antigen-Presenting Cell Delivering 11 Immune Molecules Expands Tumor Antigen-Specific CTLs in
    Zhang L; Song S; Jin X; Wan X; Shahzad KA; Pei W; Zhao C; Shen C
    Cancer Immunol Res; 2019 Jul; 7(7):1188-1201. PubMed ID: 31113806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient amplification of melanoma-specific CD8+ T cells using artificial antigen presenting complex.
    Chang J
    Exp Mol Med; 2006 Dec; 38(6):591-8. PubMed ID: 17202834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro.
    Han H; Peng JR; Chen PC; Gong L; Qiao SS; Wang WZ; Cui ZQ; Yu X; Wei YH; Leng XS
    Biochem Biophys Res Commun; 2011 Aug; 411(3):530-5. PubMed ID: 21756876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.
    Eggermont LJ; Paulis LE; Tel J; Figdor CG
    Trends Biotechnol; 2014 Sep; 32(9):456-65. PubMed ID: 24998519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic dendritic polymeric microspheres induce enhanced T cell activation and expansion for adoptive tumor immunotherapy.
    Yang H; Sun L; Chen R; Xiong Z; Yu W; Liu Z; Chen H
    Biomaterials; 2023 May; 296():122048. PubMed ID: 36842237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale artificial antigen presenting cells for T cell immunotherapy.
    Perica K; De León Medero A; Durai M; Chiu YL; Bieler JG; Sibener L; Niemöller M; Assenmacher M; Richter A; Edidin M; Oelke M; Schneck J
    Nanomedicine; 2014 Jan; 10(1):119-29. PubMed ID: 23891987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
    Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O
    Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic Magnetosomes as Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy.
    Zhang Q; Wei W; Wang P; Zuo L; Li F; Xu J; Xi X; Gao X; Ma G; Xie HY
    ACS Nano; 2017 Nov; 11(11):10724-10732. PubMed ID: 28921946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.